Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Hinge Health, Inc.
13G/A
Amendment 1
HNGE · 433313103
|
2.1% |
2/13/2026
Event 12/31/2025
|
|||
| Alkeon Capital Management LLC | 2.1% | ||||
| Panayotis D. Sparaggis | 2.1% | ||||
|
Oric Pharmaceuticals, Inc.
13G/A
Amendment 3
ORIC · 68622P109
|
4.6% |
11/13/2025
Event 9/30/2025
|
|||
| Alkeon Capital Management LLC | 4.6% | ||||
| Panayotis D. Sparaggis | 4.6% | ||||
|
Hinge Health, Inc.
13G
HNGE · 433313103
|
5.7% |
8/13/2025
Event 6/30/2025
|
|||
| Alkeon Capital Management LLC | 5.7% | ||||
| Panayotis D. Sparaggis | 5.7% | ||||
|
OneStream, Inc.
13G/A
Amendment 1
OS · 68278B107
|
3.5% |
5/14/2025
Event 3/31/2025
|
|||
| Alkeon Capital Management LLC | 3.5% | ||||
| Panayotis D. Sparaggis | 3.5% | ||||
|
Keros Therapeutics, Inc.
13G
KROS · 492327101
|
2.7% |
2/14/2025
Event 12/31/2024
|
|||
| Alkeon Capital Management LLC | 2.7% | ||||
| Panayotis D. Sparaggis | 2.7% | ||||